A detailed history of Petrus Trust Company, Lta transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Petrus Trust Company, Lta holds 1,481 shares of MEDP stock, worth $493,898. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,481
Previous 914 62.04%
Holding current value
$493,898
Previous $369,000 65.04%
% of portfolio
0.06%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$372.0 - $424.34 $210,924 - $240,600
567 Added 62.04%
1,481 $609,000
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $260,371 - $377,765
914 New
914 $369,000
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $219,456 - $301,555
1,259 New
1,259 $236,000
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $206,386 - $281,128
-4,394 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $190,040 - $280,073
4,394 New
4,394 $263,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.4B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.